Chimeric Antigen Receptor T Cell Therapy For Solid Tumors
Chimeric antigen receptor T (CAR T) cell therapy has revolutionized the management of lymphoid malignancies. However, it is still in its early phase and is facing many obstacles in solid tumors. Therapeutic challenges in solid tumor lead to tumor target diversification and drive new innovations for...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wolters Kluwer Medknow Publications
2022-07-01
|
| Seri Bilgileri: | Hematology/Oncology and Stem Cell Therapy |
| Konular: | |
| Online Erişim: | https://journals.lww.com/10.56875/2589-0646.1028 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|